Crossmark

Nutritional impact of active hexose-correlated compound for patients with resectable or borderline-resectable pancreatic cancer treated with neoadjuvant therapy

Crossref DOI link: https://doi.org/10.1007/s00595-021-02308-3

Published Online: 2021-06-04

Published Print: 2021-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hashimoto, Daisuke

Satoi, Sohei

Yamamoto, Tomohisa

Yamaki, So

Ishida, Mitsuaki

Ryota, Hironori

Sakaguchi, Tatsuma

Hirooka, Satoshi

Inoue, Kentaro

Sekimoto, Mitsugu
License Information

Text and Data Mining valid from 2021-06-04

Version of Record valid from 2021-06-04
More Information

Article History

Received: 16 March 2021

Accepted: 29 March 2021

First Online: 4 June 2021

Declarations

:

: M Sekimoto received research funding from Amino Up Chemical Co. Ltd. The sponsor had no control over the interpretation, writing, or publication of this work.

Document is current

Any future updates will be listed below